Items where Author is "Miserez, A. R."

2013

Hatz, F. and Benz, N. and Hardmeier, M. and Zimmermann, R. and Rueegg, S. and Schindler, C. and Miserez, A. R. and Gschwandtner, U. and Monsch, A. U. and Fuhr, P.. (2013) Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's disease. Clinical Neurophysiology, 124 (11). pp. 2146-2152.

2009

Sivasankaran, B. and Degen, M. and Ghaffari, A. and Hegi, M. E. and Hamou, M. F. and Ionescu, M. C. and Zweifel, C. and Tolnay, M. and Wasner, M. and Mergenthaler, S. and Miserez, A. R. and Kiss, R. and Lino, M. M. and Merlo, A. and Chiquet-Ehrismann, R. and Boulay, J. L.. (2009) Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer research : a journal of the American Association for Cancer Research, Vol. 69. pp. 458-465.

2003

Miserez, A. R. and Scharnagl, H. and Muller, P. Y. and Mirsaidi, R. and Stähelin, H. B. and Monsch, A. and März, W. and Hoffmann, M. M.. (2003) Apolipoprotein E3Basel : new insights into a highly conserved protein region. European Journal of Clinical Investigation, Vol. 33, H. 8. pp. 677-685.

2001

Meier, C. and Staub, J. J. and Roth, C. B. and Guglielmetti, M. and Kunz, M. and Miserez, A. R. and Drewe, J. and Huber, P. and Herzog, R. and Muller, B.. (2001) TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). Journal of Clinical Endocrinology and Metabolism, 86 (10). pp. 4860-4866.

2000

Finckh, U. and von der Kammer, H. and Velden, J. and Michel, T. and Andresen, B. and Deng, A. and Zhang, J. and Müller-Thomsen, T. and Zuchowski, K. and Menzer, G. and Mann, U. and Papassotiropoulos, A. and Heun, R. and Zurdel, J. and Holst, F. and Benussi, L. and Stoppe, G. and Reiss, J. and Miserez, A. R. and Staehelin, H. B. and Rebeck, G. W. and Hyman, B. T. and Binetti, G. and Hock, C. and Growdon, J. H. and Nitsch, R. M.. (2000) Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Archives of neurology, Vol. 57, H. 11. pp. 1579-1583.

1998

Zulewski, H. and Ninnis, R. and Miserez, A. R. and Baumstark, M. W. and Keller, U.. (1998) VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100. Journal of Lipid Research, 39, (2). pp. 380-387.

1997

Zulewski, H. and Muller, Beat and Exer, P. and Miserez, A. R. and Staub, J. J.. (1997) Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. The Journal of Clinical Endocrinology and Metabolism, 82 (3). pp. 771-776.

1995

Miserez, A. R. and Keller, U.. (1995) Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology, Vol. 15, H. 10. pp. 1719-1729.

1994

Miserez, A. R. and Laager, R. and Chiodetti, N. and Keller, U.. (1994) High prevalence of familial defective apolipoprotein B-100 in Switzerland. Journal of Lipid Research, 35 (4). pp. 574-583.

Miserez, A. R. and Rossi, F. A. and Keller, U.. (1994) Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects. European journal of clinical pharmacology, Vol. 46, H. 2. pp. 107-114.

Miserez, A. R. and Keller, U.. (1994) Prävention der koronaren Herzkrankheit bei familiären Hypercholesterinämien. Therapeutische Umschau, Bd. 51, H. 10. pp. 671-676.

1993

Miserez, A. R. and Schuster, H. and Chiodetti, N. and Keller, U.. (1993) Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations. American journal of human genetics, Vol. 52, H. 4. pp. 808-826.